Table of Contents
<< Previous Issue | Feb 2003 (Vol: 2003, Issue: 33) | Next Issue >> |
- Section: Company Profile
-
SkyePharma plc
- Section: Distribution & Marketing
-
Schering AG to Market Campath® in South East Asia
-
SkyePharma Licenses Further Solaraze Rights to Shire; Makes Investment in Micap
- Section: General
-
SkyePharma’s Deal Strategy
-
Drug Delivery Alliance Development Process
-
Therapy Focus: Age-related Macular Degeneration
- Section: Licensing
-
King Acquires Elan’s US Primary Care Business
-
GSK Licenses Rights to Preclinical HIV Compound
-
Watson Pharmaceuticals Enters Agreement for Novartis’ Headache Treatments
- Section: Mergers & Acquisitions
-
Roche to Bid US$1.2 B for Diabetes Firm, Disetronic
-
CAT and OGS in US$176 M Merger
-
J&J to Acquire Scios
- Section: Research & Development
-
Pharmacopeia Signs Two Collaborative R&D Deals